Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02393885 · ClinicalTrials.gov registry record · NA
Pivotal Study Of A Dual Epicardial & Endocardial Procedure (DEEP) Approach
A NA study, sponsored by AtriCure.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT02393885 is a NA study that has completed, run by AtriCure. The registered enrollment target is 90 participants.
The verdict
NCT02393885, a NA study, has completed, sponsored by AtriCure.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The objective of this study is to establish the safety and effectiveness of a dual epicardial and endocardial ablation procedure for patients presenting with Persistent Atrial Fibrillation or Longstanding Persistent Atrial Fibrillation
Interventions
- DEVICE AtriCure Bipolar System and AtriClip® PRO LAA Exclusion System, Endocardial Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2015-02 |
| Est. Completion | 2024-04-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02393885
The ClinicalTrials.gov registry entry for NCT02393885 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AtriCure, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AtriCure Bipolar System and AtriClip® PRO LAA Exclusion System, Endocardial Ablation is the first listed.
NCT02393885 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02393885 about?
NCT02393885 is a clinical study titled "Pivotal Study Of A Dual Epicardial & Endocardial Procedure (DEEP) Approach". The objective of this study is to establish the safety and effectiveness of a dual epicardial and endocardial ablation procedure for patients presenting with Persistent Atrial Fibrillation or Longstanding Persistent Atrial Fibrillation
What is the current status of trial NCT02393885?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2015-02. Estimated completion is 2024-04-17.
What interventions are being tested in trial NCT02393885?
The interventions under investigation include: AtriCure Bipolar System and AtriClip® PRO LAA Exclusion System, Endocardial Ablation (DEVICE).
Who is sponsoring clinical trial NCT02393885?
This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.